Compare Select Medical Holdings Corporation (SEM) vs Visa Inc (V) Price & Performance

Select Medical Holdings Corporation (SEM) trades at $16.51, unchanged on the day, following its recent acquisition completion by a consortium led by Robert A. Ortenzio and Martin F. at $16.50 per share. The stock exhibits a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, the company reported 2025 revenue of $5.45 billion with a net income margin of 2.42%, while valuation ratios like a P/E of 15.43 and P/S of 0.36 appear reasonable. Recent earnings show two misses in the last three quarters against expectations.

The investment outlook is dominated by the completed acquisition, effectively capping upside near the $16.50 deal price. Risks include ongoing shareholder litigation alleging fiduciary breaches by the board regarding the buyout fairness. Analyst sentiment is neutral with a Hold-heavy consensus, while the stock's future price action will largely hinge on legal outcomes surrounding the acquisition terms rather than operational performance.

Visa (V) trades at $355.85, down 0.76% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $396.70 implying 11.5% upside. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $3.31 exceeding the $3.10 estimate, and maintains robust profitability with a net income margin over 51%. Recent news highlights Visa's focus on AI-driven commerce and stablecoin partnerships to enhance its payment network.

Visa's outlook remains positive due to consistent earnings growth, high margins, and strategic initiatives in AI and digital payments. Key risks include competitive pressures from fintech and regulatory scrutiny. With 85% of analysts rating it a Buy and institutional ownership increasing, the stock presents a compelling long-term opportunity, though investors should monitor execution on innovation and macroeconomic impacts on consumer spending.